เอกสารอ้างอิง
[1]. พรทวี เลิศศรีสถิต,สุชีลา จัทร์วิทยานุชิต. ยาต้านอักเสบชนิดไม่ใช่สเตียรอยด์ (Non-steroidal Anti-inflammatory drugs).Available from :
https://www.rama.mahidol.ac.th/med/sites/default/files/public/pdf/medicinebook1/NSAIDS.pdf. Access on Nov. 20, 2022.
[2]. K. Suresh Babu, MD, DNB; and Sundeep S. Salvi, MD, DNB,PhD,From the Department of Respiratory Cell and Molecular Biology, University of Southampton, Southampton General Hospital, Southampton, UK. Aspirin and Asthma. Available from : https://www.medscape.com/viewarticle/405963. Access on Nov. 16, 2022.
[3]. Jenkins C. Recommending analgesics for people with asthma. Am J Ther. 2000 Mar;7(2):55-61. doi: 10.1097/00045391-200007020-00003. PMID: 11319574.
[4]. Global strategy for asthma management and prevention uptodate 2022. Available from : https://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf. Access on Nov. 17, 2022.
[5]. Seong-Dae Woo, Quoc Quang Luu, Hae-Sim Park, NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care, Frontiers in Pharmacology, 10.3389/fphar.2020.01147, 11, (2020). Available from : https://www.frontiersin.org/articles/10.3389/fphar.2020.01147/full. Access on Nov. 17, 2022.
[6]. Tanya ML, Elliot I. Aspirin-exacerbated respiratory disease [Internet]. 2020 [cited 2022 Nov 24]. Available from: http://www.uptodate.com
[7]. Heidi Andersén , Pinja Ilmarinen , Jasmin Honkamäki , Leena E. Tuomisto , Hanna Hisinger-Mölkänen , Helena Backman , Bo Lundbäck , Eva Rönmark , Tari Haahtela , Anssi Sovijärvi , Lauri Lehtimäki , Päivi Piirilä , Hannu Kankaanranta.NSAID-exacerbated respiratory disease: a population study.Available from :https://pubmed.ncbi.nlm.nih.gov/35083326/
[8]. Pei-Chia Lo, MDa, Yueh-Ting Tsai, MD, PhDa, Shun-Ku Lin, MDb, Jung-Nien Lai, MD, PhDa, Risk of asthma exacerbation associated with nonsteroidal anti-inflammatory drugs in childhood asthma. A nationwide population-based cohort study in Taiwan.Available from : https://journals.lww.com/md-journal/fulltext/2016/10110/risk_of_asthma_exacerbation_associated_with.32.aspx.
[9]. Anthony J. Trevor, Bertram G. Katzung, Marieke M. Kruidering-Hall, Susan B. Masters.Katzung & Trevor's Pharmacology: Examination & Board Review, 10e Chapter 20. Drugs Used in Asthma & Chronic Obstructive Pulmonary Disease .Available from: https://accesspharmacy.mhmedical.com/content.aspx?bookid=514§ionid=41817534.
[10]. Yong Ju Lee, MD, Chang-Keun Kim, MD. Montelukast use over the past20 years:monitoring of its effects and safety issues.Clinical and Experimental Pediatrics 200;63(10):376-381.Published online : February 5,2020 DOI: https://doi.org/10.3345/cep.2019.00325
[11]. Merck & CO.,INC.Whitehouse Station,NJ 08889,USA.SINGULAIR (Montelukast sodium) Tablets,Chewable tabless,and oral granules Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020829s051_020830s052_021409s028lbl.pdf.
[12]. Kam Lun ellis Hon1 Ting Fan Leung1 Alexander KC Leung2 Clinical effectiveness and safety of montelukast in asthma. what are the conclusions from clinical trials and meta-analyses? Availabile from : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079631/
[13]. Jong Sook Park, An Soo Jang,Sung Woo Park,Young Mok Lee,Soo Taek Uh,Yong Hoon Kim, Ji Yean Cha,Se Min Park,
Choon-Sik Park. Protection of leukotriene receptor antagonist against aspirin- induced bronchospasm in asthmatics. Available from : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831603/pdf/aair-2-48.pdf.